Squamous Cell Carcinoma of Head and Neck research hub

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

This study looks at treating advanced throat cancer (larynx or hypopharynx) with chemotherapy and radiation, adding a new drug, Pembrolizumab (Keytruda®). It aims to see if this new treatment can help patients keep their larynx and live longer, healthier lives.